• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by Luxfer Holdings PLC

    8/14/25 8:47:39 AM ET
    $LXFR
    Major Chemicals
    Basic Materials
    Get the next $LXFR alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    Luxfer Holdings PLC

    (Name of Issuer)


    Ordinary Shares

    (Title of Class of Securities)


    G5698W116

    (CUSIP Number)


    06/30/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    G5698W116


    1Names of Reporting Persons

    American Century Investment Management, Inc.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    1,398,652.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    1,409,329.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,409,329.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.1 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    CUSIP No.
    G5698W116


    1Names of Reporting Persons

    American Century Companies, Inc.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    1,398,652.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    1,409,329.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,409,329.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.1 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    CUSIP No.
    G5698W116


    1Names of Reporting Persons

    Stowers Institute for Medical Research
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    1,398,652.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    1,409,329.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,409,329.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.1 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Luxfer Holdings PLC
    (b)Address of issuer's principal executive offices:

    8989 North Port Washington Road, Suite 211, Milwaukee, WI, 53217
    Item 2. 
    (a)Name of person filing:

    American Century Investment Management, Inc. American Century Companies, Inc. Stowers Institute for Medical Research
    (b)Address or principal business office or, if none, residence:

    4500 Main Street 9th Floor Kansas City, Missouri 64111
    (c)Citizenship:

    Delaware
    (d)Title of class of securities:

    Ordinary Shares
    (e)CUSIP No.:

    G5698W116
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    See the response(s) to Item 9 on the attached cover page(s).
    (b)Percent of class:

    See the response(s) to Item 11 on the attached cover page(s).
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    See the response(s) to Item 5 on the attached cover page(s).

     (ii) Shared power to vote or to direct the vote:

    See the response(s) to Item 6 on the attached cover page(s).

     (iii) Sole power to dispose or to direct the disposition of:

    See the response(s) to Item 7 on the attached cover page(s).

     (iv) Shared power to dispose or to direct the disposition of:

    See the response(s) to Item 8 on the attached cover page(s).

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    Various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. ("ACIM") serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that are the subject of this schedule. Except as may be otherwise indicated if this is a joint filing, not more than 5% of the class of securities that is the subject of this schedule is owned by any one client advised by ACIM.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    This Item identifies each subsidiary of American Century Companies, Inc. ("ACC"), which is controlled by the Stowers Institute for Medical Research, that is a beneficial owner of securities that are subject of this schedule (the "Subject Securities"). American Century Investment Management, Inc. ("ACIM") is a wholly-owned subsidiary of ACC and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940.
    Item 8.Identification and Classification of Members of the Group.
     
    If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.


    Not applicable
    Item 9.Notice of Dissolution of Group.
     
    Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.


    Not applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    American Century Investment Management, Inc.
     
    Signature:American Century Investment Management, Inc.
    Name/Title:/s/ John Pak / Senior Vice President
    Date:08/14/2025
     
    American Century Companies, Inc.
     
    Signature:American Century Companies, Inc.
    Name/Title:/s/ John Pak / Senior Vice President
    Date:08/14/2025
     
    Stowers Institute for Medical Research
     
    Signature:Stowers Institute for Medical Research
    Name/Title:/s/ Joselyn Verschelden / Authorized Signer
    Date:08/14/2025
    Exhibit Information

    EXHIBIT Each of the undersigned hereby agrees and consents to the execution and joint filing on its behalf by American Century Investment Management, Inc. of this Schedule 13G respecting the beneficial ownership of the securities which are the subject of this schedule. Dated this 14th day of August, 2025. AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. ("ACIM") AMERICAN CENTURY COMPANIES, INC. ("ACC") By: __/s/ John Pak________ John Pak Senior Vice President, ACIM and ACC STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC By: __/s/ Joselyn Verschelden_____ Joselyn Verschelden Authorized Signer

    Get the next $LXFR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LXFR

    DatePrice TargetRatingAnalyst
    2/23/2022$26.50 → $27.00Buy
    B. Riley Securities
    More analyst ratings

    $LXFR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Webster Stephen converted options into 8,284 units of Ordinary Shares and sold $50,207 worth of Ordinary Shares (4,244 units at $11.83), increasing direct ownership by 18% to 26,662 units (SEC Form 4)

    4 - LUXFER HOLDINGS PLC (0001096056) (Issuer)

    6/11/25 7:34:10 AM ET
    $LXFR
    Major Chemicals
    Basic Materials

    Director Hipple Richard J sold $41,162 worth of Ordinary Shares (4,108 units at $10.02) and converted options into 9,207 units of Ordinary Shares, increasing direct ownership by 48% to 15,803 units (SEC Form 4)

    4 - LUXFER HOLDINGS PLC (0001096056) (Issuer)

    6/10/25 1:38:24 PM ET
    $LXFR
    Major Chemicals
    Basic Materials

    Director Stein Sylvia Ann converted options into 9,207 units of Ordinary Shares and sold $41,162 worth of Ordinary Shares (4,108 units at $10.02), increasing direct ownership by 106% to 9,901 units (SEC Form 4)

    4 - LUXFER HOLDINGS PLC (0001096056) (Issuer)

    6/10/25 12:28:22 PM ET
    $LXFR
    Major Chemicals
    Basic Materials

    $LXFR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Luxfer Appoints Stewart Watson to Board of Directors

    Luxfer Holdings PLC (NYSE:LXFR) ("Luxfer" or the "Company"), a global industrial company innovating niche applications of advanced materials, today announced the appointment of Stewart Watson, a UK national, as a Non-Executive Director to its Board, effective September 1, 2025. Upon joining the Board, Mr. Watson will serve on the Nominating and Governance Committee and the Audit Committee. Mr. Watson is a CIMA qualified accountant and a seasoned executive with more than 35 years of leadership experience, including over two decades in the aerospace and defense industry. He spent 23 years at Meggitt PLC, where he held several senior positions, including President of the Meggitt Equipment Gr

    8/13/25 4:25:00 PM ET
    $LXFR
    Major Chemicals
    Basic Materials

    Luxfer Reports Strong Second Quarter 2025

    Solid Top-Line Growth and Profitability Fueled by Robust Demand within Defense and Aerospace Second Quarter 2025 Highlights* GAAP Net Sales of $104.0 million, up 4.3% from $99.7 million; Adjusted Net Sales1 increased 5.8% to $97.1 million Gross Profit increased to $24.0 million, a 9.1% increase from $22.0 million Adjusted Gross Profit1 rose 13.2% to $23.2 million, with Adjusted Gross Margins of 23.9%, an improvement of 160bps GAAP Net Income of $5.0 million, compared to a $0.4 million loss in the prior year, with GAAP Diluted EPS of $0.18 Adjusted EBITDA1 of $14.0 million up 14.8% and Adjusted Diluted EPS1 of $0.30, up 25.0% from $0.24 Sale of Graphic Arts completed on J

    7/29/25 4:18:00 PM ET
    $LXFR
    Major Chemicals
    Basic Materials

    Luxfer Announces Date of Second Quarter 2025 Earnings Conference Call

    Luxfer Holdings PLC (NYSE:LXFR) ("Luxfer" or the "Company"), a global industrial company innovating niche applications in materials engineering, today announced the following details for its second quarter 2025 conference call. Date and time: Wednesday July 30, 2025, at 8:30 a.m. Eastern Time     Luxfer participants: Andy Butcher Chief Executive Officer Steve Webster Chief Financial Officer Kevin Grant Vice President of Investor Relations and Business Development     Dial-in registration: United States or Canada: 800-445-7795 International: (+1) 785-424-1699 Conference ID: LXFRQ225

    7/16/25 4:15:00 PM ET
    $LXFR
    Major Chemicals
    Basic Materials

    $LXFR
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Luxfer Holdings PLC

    SCHEDULE 13G - LUXFER HOLDINGS PLC (0001096056) (Subject)

    8/14/25 8:47:39 AM ET
    $LXFR
    Major Chemicals
    Basic Materials

    Luxfer Holdings PLC filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - LUXFER HOLDINGS PLC (0001096056) (Filer)

    8/14/25 6:57:41 AM ET
    $LXFR
    Major Chemicals
    Basic Materials

    Luxfer Holdings PLC filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - LUXFER HOLDINGS PLC (0001096056) (Filer)

    8/6/25 4:02:23 PM ET
    $LXFR
    Major Chemicals
    Basic Materials

    $LXFR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Webster Stephen bought $17,007 worth of Ordinary Shares (1,475 units at $11.53), increasing direct ownership by 7% to 22,622 units (SEC Form 4)

    4 - LUXFER HOLDINGS PLC (0001096056) (Issuer)

    5/23/25 10:38:59 AM ET
    $LXFR
    Major Chemicals
    Basic Materials

    Webster Stephen bought $10,152 worth of Ordinary Shares (1,200 units at $8.46), increasing direct ownership by 7% to 18,025 units (SEC Form 4)

    4 - LUXFER HOLDINGS PLC (0001096056) (Issuer)

    11/17/23 9:11:16 PM ET
    $LXFR
    Major Chemicals
    Basic Materials

    Butcher Andrew bought $49,967 worth of Ordinary Shares (5,800 units at $8.62), increasing direct ownership by 5% to 124,534 units (SEC Form 4)

    4 - LUXFER HOLDINGS PLC (0001096056) (Issuer)

    11/3/23 9:03:44 PM ET
    $LXFR
    Major Chemicals
    Basic Materials

    $LXFR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities reiterated coverage on Luxfer with a new price target

    B. Riley Securities reiterated coverage of Luxfer with a rating of Buy and set a new price target of $27.00 from $26.50 previously

    2/23/22 10:52:09 AM ET
    $LXFR
    Major Chemicals
    Basic Materials

    Roth Capital reiterated coverage on Luxfer Holdings with a new price target

    Roth Capital reiterated coverage of Luxfer Holdings with a rating of Buy and set a new price target of $32.00 from $30.00 previously

    4/29/21 12:34:10 PM ET
    $LXFR
    Major Chemicals
    Basic Materials

    Roth Capital reiterated coverage on Luxfer Holdings with a new price target

    Roth Capital reiterated coverage of Luxfer Holdings with a rating of Buy and set a new price target of $30.00 from $22.50 previously

    3/16/21 8:29:51 AM ET
    $LXFR
    Major Chemicals
    Basic Materials

    $LXFR
    Financials

    Live finance-specific insights

    View All

    Luxfer Announces Date of Second Quarter 2025 Earnings Conference Call

    Luxfer Holdings PLC (NYSE:LXFR) ("Luxfer" or the "Company"), a global industrial company innovating niche applications in materials engineering, today announced the following details for its second quarter 2025 conference call. Date and time: Wednesday July 30, 2025, at 8:30 a.m. Eastern Time     Luxfer participants: Andy Butcher Chief Executive Officer Steve Webster Chief Financial Officer Kevin Grant Vice President of Investor Relations and Business Development     Dial-in registration: United States or Canada: 800-445-7795 International: (+1) 785-424-1699 Conference ID: LXFRQ225

    7/16/25 4:15:00 PM ET
    $LXFR
    Major Chemicals
    Basic Materials

    Luxfer Declares Quarterly Dividend

    Luxfer Holdings PLC (NYSE:LXFR) ("Luxfer" or the "Company"), a global industrial company innovating niche applications in materials engineering, today announced that its Board of Directors declared a quarterly dividend of 13 cents per ordinary share. The dividend will be payable on August 6, 2025 to shareholders of record as of the close of business on July 18, 2025. About Luxfer Holdings PLC Luxfer is a global industrial company innovating niche applications in materials engineering. Using its broad array of proprietary technologies, Luxfer focuses on value creation, customer satisfaction, and demanding applications where technical know-how and manufacturing expertise combine to deli

    7/7/25 6:33:00 PM ET
    $LXFR
    Major Chemicals
    Basic Materials

    Luxfer Announces Date of First Quarter 2025 Earnings Conference Call

    Luxfer Holdings PLC (NYSE:LXFR) ("Luxfer" or the "Company"), a global industrial company innovating niche applications in materials engineering, today announced the following details for its first quarter 2025 conference call. Date and time: Wednesday April 30, 2025, at 8:30 a.m. Eastern Time   Luxfer participants: Andy Butcher Chief Executive Officer Steve Webster Chief Financial Officer Kevin Grant Vice President of Investor Relations and Business Development   Dial-in registration: United States or Canada: 800-274-8461 International: (+1) 203-518-9814 Conference ID: LXFRQ125 Please dial into the call 15 minu

    4/16/25 4:15:00 PM ET
    $LXFR
    Major Chemicals
    Basic Materials

    $LXFR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Luxfer Holdings PLC

    SC 13G/A - LUXFER HOLDINGS PLC (0001096056) (Subject)

    11/12/24 4:05:06 PM ET
    $LXFR
    Major Chemicals
    Basic Materials

    Amendment: SEC Form SC 13G/A filed by Luxfer Holdings PLC

    SC 13G/A - LUXFER HOLDINGS PLC (0001096056) (Subject)

    11/4/24 1:43:49 PM ET
    $LXFR
    Major Chemicals
    Basic Materials

    SEC Form SC 13G/A filed by Luxfer Holdings PLC (Amendment)

    SC 13G/A - LUXFER HOLDINGS PLC (0001096056) (Subject)

    6/6/24 9:54:34 AM ET
    $LXFR
    Major Chemicals
    Basic Materials

    $LXFR
    Leadership Updates

    Live Leadership Updates

    View All

    Luxfer Appoints Stewart Watson to Board of Directors

    Luxfer Holdings PLC (NYSE:LXFR) ("Luxfer" or the "Company"), a global industrial company innovating niche applications of advanced materials, today announced the appointment of Stewart Watson, a UK national, as a Non-Executive Director to its Board, effective September 1, 2025. Upon joining the Board, Mr. Watson will serve on the Nominating and Governance Committee and the Audit Committee. Mr. Watson is a CIMA qualified accountant and a seasoned executive with more than 35 years of leadership experience, including over two decades in the aerospace and defense industry. He spent 23 years at Meggitt PLC, where he held several senior positions, including President of the Meggitt Equipment Gr

    8/13/25 4:25:00 PM ET
    $LXFR
    Major Chemicals
    Basic Materials

    Janus International Appoints Heather Harding to Board of Directors

    Janus International Group, Inc. (NYSE:JBI) ("Janus" or the "Company"), a leading provider of cutting-edge access control technologies and building product solutions for the self-storage and other commercial and industrial sectors, today announced the appointment of Heather Harding to its Board of Directors as a Class I Director and as a member of its Audit Committee, effective July 7, 2022. Over the past 25 years, Harding has held finance leadership roles of increasing responsibility in global industrial companies. Harding served as Chief Financial Officer of Luxfer Holdings PLC (NYSE:LXFR) from January 2018 until March 2022. Prior to that she served as Vice President of Finance for Eaton

    7/7/22 7:00:00 AM ET
    $JBI
    $LXFR
    Building Products
    Industrials
    Major Chemicals
    Basic Materials

    Luxfer Announces Appointment of Sylvia A. Stein to Board of Directors

    Luxfer Holdings PLC (NYSE:LXFR) ("Luxfer" or the "Company"), a global industrial company innovating niche applications in materials engineering, today announced the appointment of Sylvia A. Stein to the Company's Board of Directors, effective August 1, 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220630005131/en/Sylvia A. Stein (Photo: Business Wire) Upon joining the Board, Ms. Stein will serve on the Nominating and Governance Committee and the Audit Committee. With the addition of Ms. Stein, Luxfer's Board of Directors is comprised of six members. "We are pleased to welcome Sylvia to our Board," said Patrick Mullen, Lux

    6/30/22 8:30:00 AM ET
    $KHC
    $LXFR
    $MOD
    Packaged Foods
    Consumer Staples
    Major Chemicals
    Basic Materials